当前位置:首页 - 行情中心 - 生物股份(600201) - 财务分析 - 现金流量表

生物股份

(600201)

  

流通市值:116.96亿  总市值:116.96亿
流通股本:11.12亿   总股本:11.12亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金984,230,016.8626,752,403.92297,554,658.331,318,502,472.36
  收到其他与经营活动有关的现金93,464,336.1868,051,888.36,181,897.199,756,534.96
  经营活动现金流入小计1,077,694,352.98694,804,292.22303,736,555.431,418,259,007.32
  购买商品、接受劳务支付的现金317,328,839.39223,183,370.78115,881,816.17283,644,422.14
  支付给职工以及为职工支付的现金181,678,173.26124,768,272.774,071,212.02247,408,993.95
  支付的各项税费74,032,188.7455,072,186.1916,626,521.297,752,734.68
  支付其他与经营活动有关的现金313,029,790.84202,837,118.9670,938,608.05499,900,642.45
  经营活动现金流出小计886,068,992.23605,860,948.63277,518,157.441,128,706,793.22
  经营活动产生的现金流量净额191,625,360.7588,943,343.5926,218,397.99289,552,214.1
二、投资活动产生的现金流量:
  收回投资收到的现金155,877,998.28155,877,998.28-10,500,000
  取得投资收益收到的现金6,706,070.366,706,070.363,041,540.3844,236,208.09
  处置固定资产、无形资产和其他长期资产收回的现金净额77,572.8217,766.9910,000844,765.77
  收到的其他与投资活动有关的现金103,489,302.266,125,634.9610,000,000684,203,299.67
  投资活动现金流入小计266,150,943.66228,727,470.5913,051,540.38739,784,273.53
  购建固定资产、无形资产和其他长期资产支付的现金57,499,248.7430,678,394.5511,340,579.7789,666,302.78
  投资支付的现金16,000,00016,000,00016,000,0004,000,000
  支付其他与投资活动有关的现金82,690,00070,000,00040,000,0001,099,264,149.17
  投资活动现金流出小计156,189,248.74116,678,394.5567,340,579.771,192,930,451.95
  投资活动产生的现金流量净额109,961,694.92112,049,076.04-54,289,039.39-453,146,178.42
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,000,0002,000,0002,000,000-
  其中:子公司吸收少数股东投资收到的现金5,000,0002,000,0002,000,000-
  取得借款收到的现金---15,000,000
  收到其他与筹资活动有关的现金3,486,6703,486,6703,486,6708,251,859.72
  筹资活动现金流入小计8,486,6705,486,6705,486,67023,251,859.72
  分配股利、利润或偿付利息支付的现金34,675,407.4933,138,942.8283,37589,365,410.08
  支付其他与筹资活动有关的现金232,071,055.28228,706,528.2499,889,697.059,129,552.46
  筹资活动现金流出小计266,746,462.77261,845,471.0699,973,072.0598,494,962.54
  筹资活动产生的现金流量净额-258,259,792.77-256,358,801.06-94,486,402.05-75,243,102.82
四、汇率变动对现金及现金等价物的影响---1,272.45
五、现金及现金等价物净增加额43,327,262.9-55,366,381.43-122,557,043.45-238,835,794.69
  加:期初现金及现金等价物余额813,924,373.52813,924,373.52820,199,434.21,052,760,168.21
  期末现金及现金等价物余额857,251,636.42758,557,992.09697,642,390.75813,924,373.52
补充资料:
  净利润-58,675,416.45-104,154,092.64
  资产减值准备-4,373,994.18-31,072,325.92
  固定资产和投资性房地产折旧-76,728,164.53-151,298,564.93
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-76,728,164.53--
  无形资产摊销-52,667,403.43-63,880,823.47
  长期待摊费用摊销-855,950.91-1,349,681.42
  处置固定资产、无形资产和其他长期资产的损失-51,912.84--2,575,161.17
  固定资产报废损失-250,829.84-1,093,085.96
  公允价值变动损失-110,945.37--2,815,245.68
  财务费用--22,000,409.94--43,997,628.34
  投资损失--15,045,803.24-12,301,592.56
  递延所得税-633,475.26-500,663.54
  其中:递延所得税资产减少-1,455,250.93--854,377.16
    递延所得税负债增加--821,775.67-1,355,040.7
  存货的减少--2,622,302.31-14,253,854.53
  经营性应收项目的减少-4,665,582.31-14,988,802.91
  经营性应付项目的增加--71,741,473.61--83,778,586.31
  不涉及现金收支的投资和筹资活动金额其他项目-0-0
  现金的期末余额-758,557,992.09-813,924,373.52
  减:现金的期初余额-813,924,373.52-1,052,760,168.21
  现金及现金等价物的净增加额--55,366,381.43--238,835,794.69
公告日期2025-10-282025-08-202025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑